Tom Luke

Title: The Innovative Contributions of Tom Luke

Introduction

Tom Luke is a notable inventor based in Sioux Falls, SD (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for coronavirus disease. His work exemplifies the intersection of innovation and practical application in medical science.

Latest Patents

Tom Luke holds a patent for "Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof." This patent provides human polyclonal immunoglobulin products designed for treating or preventing coronavirus disease. The methods outlined in the patent involve creating such compositions in a transgenic ungulate, specifically utilizing a transchromosomic bovine (TcB) system. He has 1 patent to his name.

Career Highlights

Throughout his career, Tom Luke has been associated with Sab Biotherapeutics, Inc., a company focused on developing innovative therapies. His work at the company has been pivotal in advancing treatments that leverage the unique properties of transgenic animals.

Collaborations

Tom has collaborated with several talented individuals in his field, including Hua Wu and Kristi A Egland. These collaborations have contributed to the success of his projects and the advancement of biotherapeutic solutions.

Conclusion

Tom Luke's innovative work in biotechnology, particularly in the development of treatments for coronavirus, showcases his commitment to improving public health. His contributions are a testament to the power of innovation in addressing global health challenges.